陈忠彦 钟瑞霞 秦雅静

    [摘要] 轻型颅脑创伤(mTBI)发生率居高不下，成为世界性公共健康问题。临床上迫切需要更好的实践指南以规范mTBI诊疗，进而为mTBI患者提供安全返回工作岗位的时间表。影像学检查在mTBI诊断方面尚不敏感，开发一套能够反映mTBI潜在病理生理学的生物标志物将有助于mTBI的临床诊断和预后评估。本文基于mTBI的病理解剖及病理生理学，系统阐述血脑屏障破坏、轴索损伤、神经炎性反应及基因生物标志物研究进展，旨在发现一些可在临床上推广的生物标志物，推动mTBI的客观诊断及个性化治疗。

    [关键词] 轻型颅脑创伤；生物标志物；病理学；诊断

    [中图分类号] R446 [文献标识码] A [文章编号] 1673-7210(2018)09(c)-0021-05

    [Abstract] The incidence of mild traumatic brain injury (mTBI) has remained high and has become a worldwide public health problem. There is a pressing need for better practice guidelines in clinic to standardize mTBI clinics， thereby providing mTBI patients with a timetable to return to work safe. Imaging studies are not yet sensitive to the diagnosis of mTBI， and the development of a set of biomarkers that can reflect the underlying pathophysiology of mTBI， that will contribute to clinical diagnosis and prognostic of mTBI. Based on the pathological anatomy and pathophysiology of mTBI， this article systematically elaborates the advancements of blood-brain barrier disruption， axonal injury， neuroinflammation， and gene biomarkers ......